A detailed history of Ikarian Capital, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 887,230 shares of RZLT stock, worth $4.69 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
887,230
Previous 903,744 1.83%
Holding current value
$4.69 Million
Previous $3.89 Million 10.73%
% of portfolio
0.75%
Previous 1.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.13 - $5.31 $68,202 - $87,689
-16,514 Reduced 1.83%
887,230 $4.3 Million
Q2 2024

Aug 14, 2024

BUY
$2.29 - $5.79 $2.07 Million - $5.23 Million
903,744 New
903,744 $3.89 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $205M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.